Experts skeptical after researchers report positive vaccine results  CNN PhilippinesView Full coverage on Google News
Researchers in China reported results from one of the first COVID-19 vaccine trials Friday, but experts who spoke to CNN were skeptical of their findings and called the data lukewarm.Researchers in China reported results from one of the first COVID-19 vaccine trials Friday, but experts who spoke to CNN were skeptical of their findings and called the data lukewarm.

Experts skeptical after researchers report positive vaccine results

A potential coronavirus vaccine developed by China's CanSino Biologics appeared safe and triggered an immune response in healthy adults. The Ad5-nCoV COVID-19 vaccine is currently in phase 2 clinical trial.A potential coronavirus vaccine developed by China's CanSino Biologics appeared safe and triggered an immune response in healthy adults. The Ad5-nCoV COVID-19 vaccine is currently in phase 2 clinical trial.

Using a series of prototype vaccines—ones used for medical research only and not intended for human use—researchers found that the interventions prevented rhesus macaques from becoming infected by the novel coronavirus. In a related experiment, macaques that tested positive for the virus were protected from re-infection when they encountered it a second time.Using a series of prototype vaccines—ones used for medical research only and not intended for human use—researchers found that the interventions prevented rhesus macaques from becoming infected by the novel coronavirus. In a related experiment, macaques that tested positive for the virus were protected from re-infection when they encountered it a second time.

Studies in monkeys show that coronavirus immunity holds up in vaccine treatments | Popular Science

The speed in developing vaccines for widespread testing this summer is impressive, but running trials involving tens of thousands of people will be an immense undertaking.The speed in developing vaccines so far is impressive, but running trials this summer involving tens of thousands of people will be a tough challenge.

Op-Ed: Fast coronavirus vaccine could bring problems - Los Angeles Times

“The U.S. government is providing billions to the drug companies to develop a COVID-19 vaccine. Once that vaccine is approved by the FDA, it must be available to all for free. We've already paid for it. This is not a time for pharmaceutical industry profiteering.”

Bernie Sanders on Twitter: "The U.S. government is providing billions to the drug companies to develop a COVID-19 vaccine. Once that vaccine is approved by the FDA, it must be available to all for free. We've already paid for it. This is not a time for pharmaceutical industry profiteering."

“This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering.”

Bernie Sanders on Twitter: "This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering."

“Glasgow joins crucial trials to test coronavirus vaccine https://t.co/HgZFUd7KxR”

Stewart McDonald MP on Twitter: "Glasgow joins crucial trials to test coronavirus vaccine https://t.co/HgZFUd7KxR"

“Coronavirus vaccine trial in China gets 'promising' early results https://t.co/rJeSfzLvVA”

Kai Diekmann on Twitter: "Coronavirus vaccine trial in China gets 'promising' early results https://t.co/rJeSfzLvVA"

The animal studies have provided new hope that an effective vaccine for humans is possible.The animal studies have provided new hope that an effective vaccine for humans is possible.

Monkeys Protected From COVID-19 With Prototype Vaccines

This week's coronavirus vaccine race news: U.S. bets big on possible vaccine, Chinese entry shows promise, experts caution 'slow is fast.'

Latest on global search for coronavirus vaccine: Three candidates show early promise

A potential coronavirus vaccine developed in China appeared safe and able to generate an immune response after an early trial in more than 100 people.The vaccine appeared safe and able to generate an immune response.

Coronavirus vaccine tested in China shows promise after early study in 100 people | Live Science

The Lancet published the phase-1 trial results of a possible COVID-19 vaccine from China. It seems to be safe and effective. But it has to go through more trials before being put on the market.

Chinese COVID-19 vaccine shows promising results - CGTN

First human trial for adenovirus type-5 vectored vaccine adequate to move into phase II, researchers sayFirst human trial for adenovirus type-5 vectored vaccine adequate to move into phase II, researchers say

COVID-19 Vax Safe, Produced Responses in Healthy Chinese Adults | MedPage Today

A pair of studies on coronavirus may help clue scientists in to developing a vaccine. The studies involved injecting the virus into monkeys, and of those that recovered, they seem to have developed an immunity to the disease.The studies were published on Wednesday, according to Reuters, which [...]A pair of studies on coronavirus may help clue scientists in to developing a vaccine. The studies [...]

Monkeys Infected With Coronavirus Develop Immunity, 2 Studies Say

Monkeys Infected With Coronavirus Develop Immunity, 2 Studies Say

Researchers find that the vaccine was tolerable and immune-producing 28 days after vaccination.Researchers find that the vaccine was tolerable and immune-producing 28 days after vaccination.

China's COVID-19 vaccine shows promise; groups warn about childhood vaccine disruptions | CIDRAP

The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans, according to new research published ...

First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response

A Chinese-developed COVID-19 adenovirus vector vaccine candidate became the first in the world to disclose complete phase one clinical trial results and declare dual immune response in the recipient on Friday, representing a significant milestone in its results and boost in confidence for current and prospective volunteers in clinical trials.

Chinese COVID-19 vaccine team praised for releasing complete data; early results promising - Global Times

An early stage trial of a Chinese coronavirus vaccine published in The Lancet medical journal found that it could be a safe and effective mAn early stage trial of a Chinese coronavirus vaccine published in The Lancet medical journal found that it could be a safe and effective m

Scientists say new Chinese vaccine may be safe after early stage trials | TheHill

An early stage trial of a Chinese coronavirus vaccine published in The Lancet medical journal found that it could be a safe and effective mAn early stage trial of a Chinese coronavirus vaccine published in The Lancet medical journal found that it could be a safe and effective m

Scientists say new Chinese vaccine may be safe after early stage trials | TheHill

Researchers found COVID-19 infection produces a strong T cell response. Here’s why they say that is good newsResearchers found COVID-19 infection produces a strong T cell response. Here’s why they say that is good news

Early Coronavirus Immunity Data Fuel Promise for a Vaccine - Scientific American

The Tianjin, China-based company, which was the first to move a vaccine into Phase II development, also became the first to published peer-reviewed data, from its Phase I study. Moderna released preliminary data this week, but it was seen as too early for interpreting its vaccine's efficacy.The Tianjin, China-based company, which was the first to move a vaccine into Phase II development, also became the first to published peer-reviewed data, from its Phase I study. Moderna released preliminary data this week, but it was seen as too early for interpreting its vaccine's efficacy.

CanSino beats Moderna again, this time to peer-reviewed, published Covid-19 vaccine data - MedCity News

Beijing, May 23 The first COVID-19 vaccine to reach phase I clinical trial is safe, well-tolerated, and capable of generating an immune response against the novel coronavirus in humans, says a new reChen said the vaccine is a potential candidate for further investigation The first COVID-19 vaccine to reach phase I clinical trial is safe, well-tolerated, and capable of generating an immune response against the novel coronavirus in humans, says a new research published in The Lancet journal.

First coronavirus vaccine human trial finds it is safe, induces immune response : The Tribune India

Data on the vaccine were published in the Lancet, the first time Phase 1 trial data from any Covid-19 vaccine have been published in a journal.Data on the vaccine were published in the Lancet, the first time Phase 1 trial data from any Covid-19 vaccine have been published in a journal.

Early study of Covid-19 vaccine developed in China sees mixed results

Chinese researchers have reported promising results from an animal trial of a potential vaccine for COVID-19. Chinese researchers have reported promising results from an animal trial of a potential vaccine for COVID-19.

COVID-19 Vaccine Trial Produced ‘Immediate’ Immune Response in Mice - Chinese Researchers - Sputnik International

Bloomberg - Are you a robot?

Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.

7 Top-Rated Biotech Stocks to Buy on the Hunt for a Vaccine | InvestorPlace

A trail blazing study of 108 adults finds the vaccine produced neutralising antibodies and T-cell response against SARS-CoV-2A trail blazing study of 108 adults finds the vaccine produced neutralising antibodies and T-cell response against SARS-CoV-2

First successful human trial of Covid-19 vaccine finds it 'safe for use' - Daily Star

The experimental vaccine is now being tested in a larger, mid-stage trial. Researchers said the early findings in 108 people support further study.The experimental vaccine is now being tested in a larger, mid-stage trial. Researchers said the early findings in 108 people support further study.

CanSino Biologics coronavirus vaccine human results - Business Insider

The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine ...The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine ...

US plans massive COVID-19 vaccine testing effort to meet year-end deadline - CNA

The first COVID-19 vaccine to reach clinical trials in humans was determined to be both safe and generate an immune response against the virus -- a "milestone" in the battle to defeat the deadly bug, a new study found.The first COVID-19 vaccine to reach clinical trials in humans was determined to be both safe and generate an immune response against the virus — a “milestone” in the battle to defeat

Coronavirus vaccine gets positive results in first human trial

Two new coronavirus studies prove that COVID-19 immunity can be obtained either via direct exposure to SARS-CoV-2 or via a vaccine. Researchers have used rhesus macaque to show that reinfection isn’t possible for COVID-19 survivors or for subjects who received vaccine candidates.Two new coronavirus studies prove that COVID-19 immunity can be obtained either via direct exposure to SARS-CoV-2 or via a vaccine. Researchers have used rhesus macaque to show that reinfection isn…

This is the best coronavirus news we’ve seen all month – BGR

A coronavirus vaccine tested for the first time in humans is safe and induces a rapid immune response, researchers at China's CanSino Biologics Inc reported on Friday in The Lancet medical journal. A coronavirus vaccine tested for the first time in humans is safe and induces a rapid immune response, researchers at China's CanSino Biologics Inc reported on Friday in The Lancet medical journal.

A Chinese drugmaker published a paper detailing promising data on a Phase 1 trial of its own Covid-19 vaccine candidate.A Chinese drugmaker published a paper detailing promising data on a Phase 1 trial of its own Covid-19 vaccine candidate.

Chinese Covid-19 Vaccine Trial Data Are a Good Sign for J&J and AstraZeneca’s Efforts - Barron's

The novel coronavirus has killed at least 335,538 people since the outbreak first emerged in China last December, according to a tally from official sources compiled by AFP at 1900 GMT on Friday.   The novel coronavirus has killed at least 335,538 people since the outbreak first emerged in China last December, according to a tally from official sources compiled by AFP at 1900 GMT on Friday.  

More than 335,000 dead from coronavirus; 5.1 million cases worldwide | ABS-CBN News

A possible vaccine against the strain of coronavirus causing the COVID-19 pandemic has seen early signs of success in China. However, we are "still a long way from a vaccine for all," a Beijing scientist warned.A possible vaccine against the strain of coronavirus causing the COVID-19 pandemic has seen early signs of success in China. However, we are "still a long way from a vaccine for all," a Beijing scientist warned.

Coronavirus vaccine human tests show initial promise | News | DW | 22.05.2020

Within two weeks of getting the vaccine, some developed so-called neutralizing antibodies, which can block SARS-CoV-2, the virus that causes COVID-19.Within two weeks of getting the vaccine, some developed so-called neutralizing antibodies, which can block SARS-CoV-2, the virus that causes COVID-19.

Coronavirus vaccine trial in China gets 'promising' early results

Monkeys that have survived Covid-19 are immune to getting it again, at least initially and several vaccines appear to have the same effectSurviving Covid-19 or receiving preliminary vaccines gives monkeys protective immunity to SARS-CoV-2. Although we don't yet know how long the protection la

Monkeys Gain Immunity From Covid-19 and Potential Vaccines | IFLScience

Here's the latest from around the world overnight.Here's the latest from around the world overnight.

Coronavirus: Latest on COVID-19 from around the world - Friday, May 22 | Newshub

As the coronavirus pandemic shows no sign of abating with the global cases of Covid-19, the disease caused by coronavirus surpassing 5.2 million and deaths crossing 338,000, the race to find a cure for it including a drug and a vaccine has also gained momentum.As the coronavirus pandemic shows no sign of abating with the global cases of Covid-19, the disease caused by coronavirus surpassing 5.2 million and deaths crossing 338,000, the race to find a cure for it including a drug and a vaccine has also gained momentum.

Covid-19 vaccine developed in China shows promising results in early human trials: Report - world news - Hindustan Times

Trial was carried out on 108 participants aged 18-60 in WuhanTrial was carried out on 108 participants aged 18-60 in Wuhan

Phase-1 trial: Adenovirus COVID-19 vaccine found safe, induces immune responses - The Hindu

In a matter of months, novel coronavirus has turned the whole world upside downIn a matter of months, novel coronavirus has turned the whole world upside down

Why the vaccine for COVID-19 is still several months away

Researchers found that monkeys given a trial vaccine or those who had the infection were immunised or resi...

Coronavirus: Monkeys resist re-infection after vaccine immunisation in US study

Developed by Beijing-based firm, the vaccine shows development of both forms of immunity  Developed by Beijing-based firm, the vaccine shows development of both forms of immunity  

Early human trial of COVID-19 vaccine gives positive results

Beijing [China], May 23 (ANI): Days after US drugmaker Moderna announced Phase one trial of its COVID-19 vaccine has shown positive results, researchers on Friday reported that a vaccine developed in China appears to be safe and may protect people from the deadly virus.Beijing [China], May 23 (ANI): Days after US drugmaker Moderna announced Phase one trial of its COVID-19 vaccine has shown positive results, researchers on Friday reported that a vaccine developed in China appears to be safe and may protect people from the deadly virus.

COVID-19 vaccine developed in China shows promising results in early trials: Report

A Phase 1 trial of a prospective COVID-19 vaccine that will soon be tested on Canadians has found it to be safe and also prompted an immune response, but researchers caution they are far from knowing whether or not it could actually protect people from the virus.A Phase 1 trial of a prospective COVID-19 vaccine that will soon be tested on Canadians has found it to be safe and also prompted an immune response, but researchers caution they are far from knowing whether or not it could actually protect people from the virus.

Researchers, on Friday, have claimed that a vaccine developed in China appears to be safe and may protect people from coronavirus. As per reports, those who received a single dose of the vaccine produced certain immune cells, called T cells, within two weeks while the antibodies needed immunity peaked at 28 days after inoculation. The trials were reportedly conducted by researchers at several laboratories and included 108 participants aged 18-60. Dr Daniel Barouch, director of vaccine researchResearchers, on Friday, have claimed that a vaccine developed in China appears to be safe and may protect people from coronavirus. As per reports, those who received a single dose of the vaccine produced certain immune cells, called T cells, within two weeks while the antibodies needed immunity peaked at 28 days after inoculation.

Vaccine developed in China appears to be safe, may protect people from coronavirus: Report | World News – India TV